Similar articles

• A new medication for the worst addiction.

  O'Brien CP. O'Brien CP. Curr Psychiatry Rep. 2007 Oct;9(5):345-6. Curr Psychiatry Rep. 2007. PMID: 17915070 No abstract available.
• Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.

  Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR. Nides M, et al. Arch Intern Med. 2006 Aug 14-28;166(15):1561-8. doi: 10.1001/archinte.166.15.1561. Arch Intern Med. 2006. PMID: 16908788 Clinical Trial.
• Varenicline (Chantix) for tobacco dependence.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2006 Aug 14-28;48(1241-1242):66-8. Med Lett Drugs Ther. 2006. PMID: 16977281 No abstract available.
• Practical implementation of varenicline as an aid to smoking cessation in clinical practice.

  Tonstad S. Tonstad S. Pneumologia. 2009 Jul-Sep;58(3):167-74. Pneumologia. 2009. PMID: 19817313 Review.
• Drugs for tobacco dependence.

  [No authors listed] [No authors listed] Treat Guidel Med Lett. 2008 Sep;6(73):61-6. Treat Guidel Med Lett. 2008. PMID: 18719526 Review. No abstract available.